A new study by LMU and Helmholtz Munich shows how pathogens control changes in their cell surface to evade the immune system.

Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...

Genmab wisely chose not to pursue GEN3014 further, focusing instead on its existing pipeline projects. Click here to read an ...

Squibb announced that the European Commission has granted approval to Breyanzi, a CD19-directed chimeric antigen receptor T ...

A cohort study of over 40,000 patients suggests that levels should be monitored for at least three months — longer than commonly practiced ...

Investigators assess the impact of increasing persistent PSA levels on prostate cancer–specific mortality and all-cause ...

After surgical removal of the prostate to treat prostate cancer, clinicians monitor prostate specific antigen (PSA) levels.

A new study by LMU and Helmholtz Munich shows how pathogens control changes in their cell surface to evade the immune system.

VUMC has been awarded up to $30 million from the Advanced Research Projects Agency for Health (ARPA-H) to build a massive ...